Cannabinoid clinical trials are being conducted worldwide to explore the potential of cannabinoids in various treatments, conditions, and diseases. More than 450 clinical trials have been completed or are currently underway¹. These studies are conducted in different countries, including the United States, the United Kingdom, the Netherlands, and Israel¹. The majority of ongoing trials are “interventional” studies, where participants receive one or more interventions or treatments¹.

The United States has a large population pool, a developed network of experienced investigators, a supportive regulatory framework, and a vast market of drug consumption. As a result, most ongoing or upcoming clinical trials are taking place in the US¹. The United Kingdom and the Netherlands are also actively involved in cannabinoid clinical trials. Together, they account for around 71% of the active cannabinoid clinical trials in Europe¹. Israel is another country with significant involvement in cannabis-related research, participating in over 20 active/completed clinical trials¹.

As for companies involved in cannabinoid clinical trials, there are several notable players. Some of them include:

• GW Pharmaceuticals (U.K.)
• Sanofi (France)
• GW Research (U.K.)
• Solvay Pharmaceuticals (Belgium)
• INSYS Therapeutics Inc. (U.S.)
• e-Therapetuics (U.K.)
• Pfizer (U.S.)
• Tetra Bio-Pharma (Canada)
• AstraZeneca (U.K.)
• PhytoTech Therapeutics (Australia)
• Portola Pharmaceuticals (U.S.)
• Par Pharmaceuticals (U.S.)
• Intron Biotechnology (China)
• TO Pharmaceuticals (Israel)
• GlaxoSmithKline (U.K.)
• Cannabics Pharmaceuticals (U.S.)²

For more information on cannabinoid clinical trials, you can refer to this source.

Please note that while clinical trials are essential for advancing medical knowledge, it is important to consult healthcare professionals for personalized advice and guidance regarding specific treatments or conditions.

Learn more:

1. cannabishealthnews.co.uk2. statista.com3. cannabishealthnews.co.uk4. visualcapitalist.com5. frontiersin.org+3 more

universities involved

Cannabinoid clinical trials are being conducted worldwide to explore the potential of cannabinoids in various treatments, conditions, and diseases. More than 450 clinical trials have been completed or are currently underway¹. These studies are conducted in different countries, including the United States, the United Kingdom, the Netherlands, and Israel¹. The majority of ongoing trials are “interventional” studies, where participants receive one or more interventions or treatments¹.

Some universities involved in cannabinoid clinical trials include:

• Imperial College London: The Medical Cannabis Research Group at Imperial College London focuses on evaluating and developing novel cannabinoid therapies targeting inflammation, cancer, and pain².
• University of California, San Diego: The Center for Medicinal Cannabis Research at UC San Diego conducts research on the safety and efficacy of cannabis and cannabinoids for various medical conditions³.
• University of Colorado: The University of Colorado’s Anschutz Medical Campus has a Center for Medicinal Cannabis Research that conducts clinical trials to evaluate the therapeutic potential of cannabis and cannabinoids³.
• University of Oxford: The University of Oxford is involved in cannabinoid research through its Nuffield Department of Clinical Neurosciences. They conduct studies on the use of cannabinoids for pain management and other conditions³.

For more information on cannabinoid clinical trials, you can refer to this source.

Please note that while clinical trials are essential for advancing medical knowledge, it is important to consult healthcare professionals for personalized advice and guidance regarding specific treatments or conditions.

Learn more:

1. cannabishealthnews.co.uk2. imperial.ac.uk3. leafly.com4. cannabishealthnews.co.uk5. frontiersin.org+2 more

What are some common conditions studied in cannabinoid trials?

Cannabinoid clinical trials are being conducted worldwide to explore the potential of cannabinoids in various treatments, conditions, and diseases. More than 450 clinical trials have been completed or are currently underway¹. These studies are conducted in different countries, including the United States, the United Kingdom, the Netherlands, and Israel¹. The majority of ongoing trials are “interventional” studies, where participants receive one or more interventions or treatments¹.

Some common conditions studied in cannabinoid trials include:

• Pain: Cannabinoids have been studied for their potential to alleviate pain associated with various conditions such as cancer, neuropathy, and fibromyalgia².
• Multiple sclerosis (MS): Cannabinoids have been studied for their potential to reduce muscle spasticity and pain associated with MS².
• Epilepsy: Cannabinoids have been studied for their potential to reduce seizures in people with epilepsy².
• Anxiety: Cannabinoids have been studied for their potential to reduce anxiety symptoms in people with anxiety disorders³.
• Sleep disorders: Cannabinoids have been studied for their potential to improve sleep quality in people with sleep disorders³.

For more information on cannabinoid clinical trials, you can refer to this source.

Please note that while clinical trials are essential for advancing medical knowledge, it is important to consult healthcare professionals for personalized advice and guidance regarding specific treatments or conditions.

Learn more:

1. frontiersin.org2. nap.nationalacademies.org3. health.harvard.edu4. frontiersin.org5. cannabishealthnews.co.uk6. jcannabisresearch.biomedcentral.com7. fda.gov8. doi.org